Insider transactions

Schond L. Greenway

CIK 1848205 · Chief Financial Officer · last filed 2024-03-26

Schond L. Greenway is a Chief Financial Officer who has filed 17 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing shows the insider had shares withheld for taxes covering $54.4K of MNMD on Mar 26, 2024. Across all open-market trades the lifetime net is −$149.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8 across reported positions. 4 SEC filings were submitted jointly with Cerecor Inc. 4 Form 144 notices of planned sales are also on file; the latest, for DFTX on Dec 26, 2023, lists the filer as an officer. 2 sales listed on those notices, worth $113.3K in all, have no matching Form 4.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$8
Companies
3
Total Filings
17
Lifetime Open-Market Net
-$149.1K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

MNMD price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
C/O CERECOR, INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE, MD 20850
Related Filers
Cerecor Inc. — 4 joint filings, latest 2021-12-14
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Definium Therapeutics, Inc. (MNMD) Delisted Chief Financial Officer 211,057 $15.00 $3.17M -$154.3K 10 2024-03-26
AVTX CFO 1 $7.76 $8 $3.5K 1 2021-12-14
Avalo Therapeutics, Inc. (CERC) Delisted CFO 1,652 $2.93 $4.8K $1.7K 2 2021-06-14

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2024-03-26 Definium Therapeutics, Inc. (MNMD) Delisted Tax (F) −5,560 -$54.4K EDGAR
2024-02-29 Definium Therapeutics, Inc. (MNMD) Delisted Grant (A) — $0 EDGAR
2023-12-26 Definium Therapeutics, Inc. (MNMD) Delisted Sell (S) −5,652 -$20.5K EDGAR
2023-12-26 DFTX Notice (144)
Officer · Planned Dec 26, 2023 · 10b5-1 plan
No sale on file
 −5,652 -$20.5K EDGAR
2023-09-25 Definium Therapeutics, Inc. (MNMD) Delisted Sell (S) −5,762 -$20.6K EDGAR
2023-09-25 DFTX Notice (144)
Officer · Planned Sep 25, 2023 · 10b5-1 plan
No sale on file
 −3,854 -$13.8K EDGAR
2023-08-28 DFTX Notice (144)
Officer · Planned Aug 25, 2023
Sold: listed on the Sep 25, 2023 notice
 −20,000 -$77.2K EDGAR
2023-08-28 DFTX Notice (144)
Officer · Planned Aug 25, 2023 · 10b5-1 plan
Sold: listed on the Sep 25, 2023 notice
 −20,000 -$77.2K EDGAR
2023-08-28 Definium Therapeutics, Inc. (MNMD) Delisted Sell (S) −20,000 -$76.0K EDGAR
2023-06-27 Definium Therapeutics, Inc. (MNMD) Delisted Sell (S) −11,635 -$37.2K EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).

Sales Reported Only on Form 144

2 sales · $113.3K
Each Form 144 lists the seller's sales of the company's stock in the 3 months before it. These are the sales on this filer's notices that no Form 4 on file shows, which is the usual case once someone is no longer an officer or director, or for an affiliate who never files Form 4s. Each sale is listed once, with the first notice that reported it.
Sold Symbol Shares Proceeds Avg Price Listed On
2023-08-25 DFTX 20,000 $76.1K $3.80 2023-09-25
2023-06-27 DFTX 11,635 $37.2K $3.20 2023-08-28